The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Open accessAbstract
The tumor microenvironment is a complex ecosystem comprised of many different cell types, abnormal vasculature and immunosuppressive cytokines. The irregular growth kinetics with which tumors grow leads to increased oxygen consumption and, in turn, hypoxic conditions. Hypoxia has been associated with poor clinical outcome, increased tumor heterogeneity, emergence of resistant clones and evasion of immune detection. Additionally, hypoxia-driven cell death pathways have traditionally been thought of as tolerogenic processes. However, as researchers working in the field of immunotherapy continue to investigate and unveil new types of immunogenic cell death (ICD), it has become clear that, in some instances, hypoxia may actually induce ICD within a tumor. In this review, we will discuss hypoxia-driven immune escape that drives poor prognostic outcomes, the ability of hypoxia to induce ICD and potential therapeutic targets amongst hypoxia pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Nanoparticles in Photodynamic Therapy
Lucky, S. S., Soo, K. C., & Zhang, Y. (2015) · Chemical Reviews · doi:10.1021/cr5004198 · Cited by 2,980
Mitochondria and cell death: outer membrane permeabilization and beyond
Tait, S. W. G., & Green, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2952 · Cited by 2,593
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Role of angiogenesis in tumor growth and metastasis
Folkman, J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37263 · Cited by 2,404
Role of angiogenesis in tumor growth and metastasis
FOLKMAN, J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70065-1 · Cited by 2,400
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Jiang, X., Wang, J., Deng, X., Xiong, F., Ge, J., Xiang, B., Wu, X., Ma, J., Zhou, M., Li, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0928-4 · Cited by 1,457
PD-L1 Expression in Triple-Negative Breast Cancer
Mittendorf, E. A., Philips, A. V., Meric-Bernstam, F., Qiao, N., Wu, Y., Harrington, S., Su, X., Wang, Y., Gonzalez-Angulo, A. M., Akcakanat, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0127 · Cited by 1,396
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256
Immune Regulatory Function of B Cells
Mauri, C., & Bosma, A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074934 · Cited by 1,249
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Levine, A. J., & Puzio-Kuter, A. M. (2010) · Science · doi:10.1126/science.1193494 · Cited by 1,243
CTLA-4: a moving target in immunotherapy
Rowshanravan, B., Halliday, N., & Sansom, D. M. (2018) · Blood · doi:10.1182/blood-2017-06-741033 · Cited by 1,233
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
Hypoxia-Induced Angiogenesis: Good and Evil
Krock, B. L., Skuli, N., & Simon, M. C. (2011) · Genes & Cancer · doi:10.1177/1947601911423654 · Cited by 1,180
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Overcoming T cell exhaustion in infection and cancer
Pauken, K. E., & Wherry, E. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.008 · Cited by 1,171
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
Battaglia, M., Stabilini, A., & Roncarolo, M.-G. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,134
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Kim, C., Gao, R., Sei, E., Brandt, R., Hartman, J., Hatschek, T., Crosetto, N., Foukakis, T., & Navin, N. E. (2018) · Cell · doi:10.1016/j.cell.2018.03.041 · Cited by 1,104
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215397109 · Cited by 1,099
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Sukumar, M., Liu, J., Ji, Y., Subramanian, M., Crompton, J. G., Yu, Z., Roychoudhuri, R., Palmer, D. C., Muranski, P., Karoly, E. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69589 · Cited by 952
Immunoregulatory functions of mTOR inhibition
Thomson, A. W., Turnquist, H. R., & Raimondi, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2546 · Cited by 847
Consensus guidelines for the detection of immunogenic cell death
Kepp, O., Senovilla, L., Vitale, I., Vacchelli, E., Adjemian, S., Agostinis, P., Apetoh, L., Aranda, F., Barnaba, V., Bloy, N., et al. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955691 · Cited by 832
Self-citationA novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800
Lastwika, K. J., Wilson, W., Li, Q. K., Norris, J., Xu, H., Ghazarian, S. R., Kitagawa, H., Kawabata, S., Taube, J. M., Yao, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-3362 · Cited by 785
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
Holmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, Å., Gradin, K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.026 · Cited by 735
Immunogenic cell death in cancer therapy: Present and emerging inducers
Zhou, J., Wang, G., Chen, Y., Wang, H., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14356 · Cited by 719
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687
Macrophages and cancer: from mechanisms to therapeutic implications
Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 683
The integration of T cell migration, differentiation and function
Masopust, D., & Schenkel, J. M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3442 · Cited by 627
Passing the baton: the HIF switch
Koh, M. Y., & Powis, G. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.004 · Cited by 589
The urgent need to recover MHC class I in cancers for effective immunotherapy
Garrido, F., Aptsiauri, N., Doorduijn, E. M., Garcia Lora, A. M., & van Hall, T. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.007 · Cited by 585
Caro-Maldonado, A., Wang, R., Nichols, A. G., Kuraoka, M., Milasta, S., Sun, L. D., Gavin, A. L., Abel, E. D., Kelsoe, G., Green, D. R., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302062 · Cited by 549
The impact of hypoxia on tumor-associated macrophages
Henze, A.-T., & Mazzone, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84427 · Cited by 546
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528
The Contribution of Angiogenesis to the Process of Metastasis
Bielenberg, D. R., & Zetter, B. R. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000138 · Cited by 523
Hypoxia-Inducible Factor 1α Is Essential for Cell Cycle Arrest during Hypoxia
Goda, N., Ryan, H. E., Khadivi, B., McNulty, W., Rickert, R. C., & Johnson, R. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.359-369.2003 · Cited by 520
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Hughes, R., Qian, B.-Z., Rowan, C., Muthana, M., Keklikoglou, I., Olson, O. C., Tazzyman, S., Danson, S., Addison, C., Clemons, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3587 · Cited by 518
Hoffman, W., Lakkis, F. G., & Chalasani, G. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09430915 · Cited by 482
Neoantigen landscape dynamics during human melanoma–T cell interactions
Verdegaal, E. M. E., de Miranda, N. F. C. C., Visser, M., Harryvan, T., van Buuren, M. M., Andersen, R. S., Hadrup, S. R., van der Minne, C. E., Schotte, R., Spits, H., et al. (2016) · Nature · doi:10.1038/nature18945 · Cited by 461
Peng, J., Zhang, L., Drysdale, L., & Fong, G.-H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140087397 · Cited by 460 · cited 1×
“Peng and colleagues have shown that EPAS1 plays an important role in controlling vascular remodeling and that the protein level of EPAS1 is regulated by oxygen tension, where hypoxia induces stabilization of the protein [12].”
BackgroundChiu, D. K.-C., Tse, A. P.-W., Xu, I. M.-J., Di Cui, J., Lai, R. K.-H., Li, L. L., Koh, H.-Y., Tsang, F. H.-C., Wei, L. L., Wong, C.-M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00530-7 · Cited by 448
mTOR , metabolism, and the regulation of T‐cell differentiation and function
Waickman, A. T., & Powell, J. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01152.x · Cited by 420
Caldwell, C. C., Kojima, H., Lukashev, D., Armstrong, J., Farber, M., Apasov, S. G., & Sitkovsky, M. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6140 · Cited by 420
Hackstein, H., Taner, T., Zahorchak, A. F., Morelli, A. E., Logar, A. J., Gessner, A., & Thomson, A. W. (2003) · Blood · doi:10.1182/blood-2002-11-3370 · Cited by 381
Regulation of T Lymphocyte Metabolism
Frauwirth, K. A., & Thompson, C. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4661 · Cited by 371
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
Griss, J., Bauer, W., Wagner, C., Simon, M., Chen, M., Grabmeier-Pfistershammer, K., Maurer-Granofszky, M., Roka, F., Penz, T., Bock, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12160-2 · Cited by 369
The Diverse Function of PD-1/PD-L Pathway Beyond Cancer
Qin, W., Hu, L., Zhang, X., Jiang, S., Li, J., Zhang, Z., & Wang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02298 · Cited by 369
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
Chouaib, S., Noman, M. Z., Kosmatopoulos, K., & Curran, M. A. (2017) · Oncogene · doi:10.1038/onc.2016.225 · Cited by 365
Chen, Z., Liu, L., Liang, R., Luo, Z., He, H., Wu, Z., Tian, H., Zheng, M., Ma, Y., & Cai, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b04371 · Cited by 363
CD28, CTLA‐4 and their ligands: who does what and to whom?
Sansom, D. M. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00121.x · Cited by 362
Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L
Papandreou, I., Lim, A. L., Laderoute, K., & Denko, N. C. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.84 · Cited by 334
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 315
HIF Inhibitors: Status of Current Clinical Development
Fallah, J., & Rini, B. I. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0752-z · Cited by 308
MHC antigens and tumor escape from immune surveillance
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)83005-0 · Cited by 305
Role of HIF-1 in Cancer Progression: Novel Insights. A Review
Pezzuto, A., & Carico, E. (2019) · Current Molecular Medicine · doi:10.2174/1566524018666181109121849 · Cited by 305
Gsk3 is a metabolic checkpoint regulator in B cells
Jellusova, J., Cato, M. H., Apgar, J. R., Ramezani-Rad, P., Leung, C. R., Chen, C., Richardson, A. D., Conner, E. M., Benschop, R. J., Woodgett, J. R., et al. (2017) · Nature Immunology · doi:10.1038/ni.3664 · Cited by 303
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1184-2 · Cited by 292
HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
Baba, Y., Nosho, K., Shima, K., Irahara, N., Chan, A. T., Meyerhardt, J. A., Chung, D. C., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090972 · Cited by 285
Balsamo, M., Manzini, C., Pietra, G., Raggi, F., Blengio, F., Mingari, M. C., Varesio, L., Moretta, L., Bosco, M. C., & Vitale, M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343448 · Cited by 282
Decreased Expression of the DNA Mismatch Repair Gene Mlh1 under Hypoxic Stress in Mammalian Cells
Mihaylova, V. T., Bindra, R. S., Yuan, J., Campisi, D., Narayanan, L., Jensen, R., Giordano, F., Johnson, R. S., Rockwell, S., & Glazer, P. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3265-3273.2003 · Cited by 274
Meng, X., Grötsch, B., Luo, Y., Knaup, K. X., Wiesener, M. S., Chen, X.-X., Jantsch, J., Fillatreau, S., Schett, G., & Bozec, A. (2018) · Nature Communications · doi:10.1038/s41467-017-02683-x · Cited by 274
HLA class I antigen abnormalities and immune escape by malignant cells
Seliger, B., Cabrera, T., Garrido, F., & Ferrone, S. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0404 · Cited by 270
Li, Y., Wang, Y., Kim, E., Beemiller, P., Wang, C.-Y., Swanson, J., You, M., & Guan, K.-L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705231200 · Cited by 269
Development of HIF‐1 inhibitors for cancer therapy
Onnis, B., Rapisarda, A., & Melillo, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00876.x · Cited by 268
Song, M., Chen, D., Lu, B., Wang, C., Zhang, J., Huang, L., Wang, X., Timmons, C. L., Hu, J., Liu, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065821 · Cited by 266
mTORC1 Signaling under Hypoxic Conditions Is Controlled by ATM-Dependent Phosphorylation of HIF-1α
Cam, H., Easton, J. B., High, A., & Houghton, P. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.030 · Cited by 266
Hypoxia-inducible factor 1 and breast cancer metastasis
Liu, Z.-J., Semenza, G. L., & Zhang, H.-F. (2015) · Journal of Zhejiang University-SCIENCE B · doi:10.1631/jzus.b1400221 · Cited by 252
Chiu, D. K., Xu, I. M., Lai, R. K., Tse, A. P., Wei, L. L., Koh, H., Li, L. L., Lee, D., Lo, R. C., Wong, C., et al. (2016) · Hepatology · doi:10.1002/hep.28655 · Cited by 241
Carbajo-Pescador, S., Ordoñez, R., Benet, M., Jover, R., García-Palomo, A., Mauriz, J. L., & González-Gallego, J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.285 · Cited by 233
De Francesco, E. M., Lappano, R., Santolla, M. F., Marsico, S., Caruso, A., & Maggiolini, M. (2013) · Breast Cancer Research · doi:10.1186/bcr3458 · Cited by 227
Tamura, R., Tanaka, T., Akasaki, Y., Murayama, Y., Yoshida, K., & Sasaki, H. (2020) · Medical Oncology · doi:10.1007/s12032-019-1329-2 · Cited by 226
Kojima, H., Gu, H., Nomura, S., Caldwell, C. C., Kobata, T., Carmeliet, P., Semenza, G. L., & Sitkovsky, M. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052706699 · Cited by 224
Tumor hypoxia as a driving force in genetic instability
Luoto, K. R., Kumareswaran, R., & Bristow, R. G. (2013) · Genome Integrity · doi:10.1186/2041-9414-4-5 · Cited by 223
Sivridis, E., Giatromanolaki, A., Gatter, K. C., Harris, A. L., Koukourakis, M. I., & for the Tumor and Angiogenesis Research Group (2002) · Cancer · doi:10.1002/cncr.10774 · Cited by 218
The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers
Chen, J. L.-Y., Lucas, J. E., Schroeder, T., Mori, S., Wu, J., Nevins, J., Dewhirst, M., West, M., & Chi, J.-T. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000293 · Cited by 213
Hypoxia, Metabolism and Immune Cell Function
Krzywinska, E., & Stockmann, C. (2018) · Biomedicines · doi:10.3390/biomedicines6020056 · Cited by 208
Büchler, P., Reber, H. A., Büchler, M., Shrinkante, S., Büchler, M. W., Friess, H., Semenza, G. L., & Hines, O. J. (2003) · Pancreas · doi:10.1097/00006676-200301000-00010 · Cited by 206
Li, Y., Patel, S. P., Roszik, J., & Qin, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01591 · Cited by 195
Strange attractors: DAMPs and autophagy link tumor cell death and immunity
Hou, W., Zhang, Q., Yan, Z., Chen, R., Zeh III, H. J., Kang, R., Lotze, M. T., & Tang, D. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.493 · Cited by 193
Skinner, H. D., Zheng, J. Z., Fang, J., Agani, F., & Jiang, B.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404097200 · Cited by 192
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
Yu, T., Tang, B., & Sun, X. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.3.489 · Cited by 191
Ohno, S., Ohno, Y., Suzuki, N., Kamei, T., Koike, K., Inagawa, H., Kohchi, C., Soma, G., & Inoue, M. (2004) · PubMed · Cited by 186
Divergent effects of hypoxia on dendritic cell functions
Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., Chen, I.-H., Sozzani, S., Austyn, J. M., Mantovani, A., & Sica, A. (2008) · Blood · doi:10.1182/blood-2008-02-142091 · Cited by 184
Oladipupo, S., Hu, S., Kovalski, J., Yao, J., Santeford, A., Sohn, R. E., Shohet, R., Maslov, K., Wang, L. V., & Arbeit, J. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101321108 · Cited by 183
Hypoxia Compromises Anti-Cancer Immune Responses
Multhoff, G., & Vaupel, P. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-34461-0_18 · Cited by 181
Krzywinska, E., Kantari-Mimoun, C., Kerdiles, Y., Sobecki, M., Isagawa, T., Gotthardt, D., Castells, M., Haubold, J., Millien, C., Viel, T., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01599-w · Cited by 176
Hackstein, H., Taner, T., Logar, A. J., & Thomson, A. W. (2002) · Blood · doi:10.1182/blood.v100.3.1084 · Cited by 173
Messai, Y., Gad, S., Noman, M. Z., Le Teuff, G., Couve, S., Janji, B., Kammerer, S. F., Rioux-Leclerc, N., Hasmim, M., Ferlicot, S., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.11.029 · Cited by 168
Regulation of germinal center B‐cell differentiation
Zhang, Y., Garcia‐Ibanez, L., & Toellner, K. (2016) · Immunological Reviews · doi:10.1111/imr.12396 · Cited by 165
Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors
Chen, L., Endler, A., & Shibasaki, F. (2009) · Experimental and Molecular Medicine · doi:10.3858/emm.2009.41.12.103 · Cited by 164
Parodi, M., Raggi, F., Cangelosi, D., Manzini, C., Balsamo, M., Blengio, F., Eva, A., Varesio, L., Pietra, G., Moretta, L., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02358 · Cited by 151
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 149
Hypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide
Siemens, D. R., Hu, N., Sheikhi, A., Chung, E., Frederiksen, L. J., Pross, H. F., & Graham, C. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0054 · Cited by 145
Cho, S. H., Raybuck, A. L., Blagih, J., Kemboi, E., Haase, V. H., Jones, R. G., & Boothby, M. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811702116 · Cited by 143
Zhao, T., Ren, H., Jia, L., Chen, J., Xin, W., Yan, F., Li, J., Wang, X., Gao, S., Qian, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2948 · Cited by 142
Enlightening the impact of immunogenic cell death in photodynamic cancer therapy
Galluzzi, L., Kepp, O., & Kroemer, G. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.2 · Cited by 142
Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics
Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.17 · Cited by 140
Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability
Kumareswaran, R., Ludkovski, O., Meng, A. X., Sykes, J. R., Pintilie, M., & Bristow, R. G. (2012) · Journal of Cell Science · doi:10.1242/jcs.092262 · Cited by 136
Sethumadhavan, S., Silva, M., Philbrook, P., Nguyen, T., Hatfield, S. M., Ohta, A., & Sitkovsky, M. V. (2017) · PLOS ONE · doi:10.1371/journal.pone.0187314 · Cited by 119
Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea
Cubillos-Zapata, C., Avendaño-Ortiz, J., Hernandez-Jimenez, E., Toledano, V., Casas-Martin, J., Varela-Serrano, A., Torres, M., Almendros, I., Casitas, R., Fernández-Navarro, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00833-2017 · Cited by 116
Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration
Köhler, T., Reizis, B., Johnson, R. S., Weighardt, H., & Förster, I. (2012) · European Journal of Immunology · doi:10.1002/eji.201142053 · Cited by 108
Elia, A. R., Cappello, P., Puppo, M., Fraone, T., Vanni, C., Eva, A., Musso, T., Novelli, F., Varesio, L., & Giovarelli, M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208082 · Cited by 106
Tao, J.-H., Barbi, J. J., & Pan, F. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00204.2015 · Cited by 105
Ban, H. S., Kim, B., Lee, H., Kim, H. M., Harmalkar, D. S., Nam, M., Park, S., Lee, K., Park, J.-T., Kim, I., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.235 · Cited by 96
Zhang, X., Wang, Y., Fan, J., Chen, W., Luan, J., Mei, X., Wang, S., Li, Y., Ye, L., Li, S., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0812-9 · Cited by 96
Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair.
Kondo, A., Safaei, R., Mishima, M., Niedner, H., Lin, X., & Howell, S. B. (2001) · PubMed · Cited by 95
Hypoxia Causes Downregulation of Mismatch Repair System and Genomic Instability in Stem Cells
Rodríguez-Jiménez, F. J., Moreno‐Manzano, V., Lucas-Domínguez, R., & Sánchez-Puelles, J.-M. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1016 · Cited by 90
Sanchez-Perez, L. A., Kottke, T. J., Díaz, R. M., Ahmed, A. U., Thompson, J., Chong, H., Melcher, A. A., Holmen, S. L., Daniels, G. A., & Vile, R. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3216 · Cited by 86
Marijt, K. A., Sluijter, M., Blijleven, L., Tolmeijer, S. H., Scheeren, F. A., van der Burg, S. H., & van Hall, T. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0627-8 · Cited by 85
Ye, X.-Z., Yu, S., & Bian, X. (2010) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/s1673-8527(09)60061-8 · Cited by 81
PHD2: from hypoxia regulation to disease progression
Wielockx, B., & Meneses, A. (2016) · Hypoxia · doi:10.2147/hp.s53576 · Cited by 74
Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus
Aghi, M. K., Liu, T., Rabkin, S. D., & Martuza, R. L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.232 · Cited by 71
Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia
Selfridge, A. C., Cavadas, M. A. S., Scholz, C. C., Campbell, E. L., Welch, L. C., Lecuona, E., Colgan, S. P., Barrett, K. E., Sporn, P. H. S., Sznajder, J. I., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.713941 · Cited by 70
Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication
Chaoul, N., Fayolle, C., Desrues, B., Oberkampf, M., Tang, A., Ladant, D., & Leclerc, C. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0454 · Cited by 68
Zhao, L., Li, C., Liu, F., Zhao, Y., Liu, J., Hua, Y., Liu, J., Huang, J., & Ge, C. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s130481 · Cited by 63
Jing, S., Wang, Y.-D., Kuroda, M., Su, J.-W., Sun, G.-G., Liu, Q., Cheng, Y.-J., & Yang, C.-R. (2012) · PubMed · doi:10.18926/amo/48964 · Cited by 61
Garg, A. D., Dudek, A. M., & Agostinis, P. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.372 · Cited by 58
Wierzbicki, P., Kłącz, J., Kotulak‐Chrząszcz, A., Wrońska, A., Stanisławowski, M., Rybarczyk, A., Ludziejewska, A., Kmieć, Z., & Matuszewski, M. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4830 · Cited by 51
Activation of dendritic cells by tumor cell death
Cirone, M., Renzo, L. D., Lotti, L. V., et al. (2012) · OncoImmunology · doi:10.4161/onci.20428 · Cited by 47
Antigen Loss Variants: Catching Hold of Escaping Foes
Vyas, M., Müller, R., & von Strandmann, E. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00175 · Cited by 44
Expression of HIF-2α/EPAS1 in hepatocellular carcinoma
Bangoura, G., 杨连粤, Huang, G.-W., & Wang, W. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i4.525 · Cited by 42
Murthy, A., Gerber, S. A., Koch, C. J., & Lord, E. M. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900017 · Cited by 36
RIG-I Resists Hypoxia-Induced Immunosuppression and Dedifferentiation
Engel, C., Brügmann, G., Lambing, S., Mühlenbeck, L. H., Marx, S., Hagen, C., Horváth, D., Goldeck, M., Ludwig, J., Herzner, A., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0129-t · Cited by 33
Hatfield, S. M., Halpin-Veszeleiova, K., Steingold, J., Sethuraman, J., & Sitkovsky, M. V. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_8 · Cited by 32
Superior Efficacy of Tumor Cell Vaccines Grown in Physiologic Oxygen
Olin, M. R., Andersen, B. M., Zellmer, D. M., Grogan, P. T., Popescu, F. E., Xiong, Z., Forster, C. L., Seiler, C., SantaCruz, K. S., Chen, W., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1572 · Cited by 31
Han, S., Huang, T., Li, W., Liu, S., Yang, W., Shi, Q., Li, H., Ren, J., & Hou, F. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491806 · Cited by 28
Tawadros, A. I. F., & Khalafalla, M. M. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.202891 · Cited by 24
Late-stage inhibition of autophagy enhances calreticulin surface exposure
Li, D., Xie, B., Wu, X.-J., Li, J., Ding, Y., Wen, X.-Z., Zhang, X., Zhu, S.-G., Liu, W., Zhang, X.-S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13099 · Cited by 23
Han, Y. K., Park, G., Bae, M., Kim, J., Jo, W. S., & Lee, C. (2019) · Oncology Letters · doi:10.3892/ol.2019.10986 · Cited by 19
Cowman, S. J., Pizer, B. L., & Sée, V. (2021) · PeerJ · doi:10.7717/peerj.11275 · Cited by 19
Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells
Olin, M. R., Andersen, B. M., Litterman, A. J., Grogan, P. T., Sarver, A. L., Robertson, P. T., Liang, X., Chen, W., Parney, I. F., Hunt, M. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1166 · Cited by 18
Employing tumor hypoxia to enhance oncolytic viral therapy in breast cancer
Pin, R. H., Reinblatt, M., & Fong, Y. (2004) · Surgery · doi:10.1016/j.surg.2004.04.016 · Cited by 16
The impact of hypoxia on oncolytic virotherapy
Guo, Z. S. (2011) · Virus Adaptation and Treatment · doi:10.2147/vaat.s17832 · Cited by 14
Cluff, E. R., Nolan, J., Collins, C., Varadaraj, A., & Rajasekaran, N. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.202.supp.194.37 · Cited by 7
Cited by
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Wu, Q., You, L., Nepovimova, E., Heger, Z., Wu, W., Kuca, K., & Adam, V. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01292-6 · Cited by 485
Wang, B., Zhao, Q., Zhang, Y., Liu, Z., Zheng, Z., Liu, S., Meng, L., Xin, Y., & Jiang, X. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01820-7 · Cited by 315
The role of hypoxia‐inducible factor 1 in tumor immune evasion
You, L., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimova, E., Wu, Q., & Kuca, K. (2021) · Medicinal Research Reviews · doi:10.1002/med.21771 · Cited by 265
The regulation of immune checkpoints by the hypoxic tumor microenvironment
Hu, M., Li, Y., Lu, Y., Wang, M., Li, Y., Wang, C., Li, Q., & Zhao, H. (2021) · PeerJ · doi:10.7717/peerj.11306 · Cited by 51
The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Bartoszewska, S., Collawn, J. F., & Bartoszewski, R. (2022) · Cancers · doi:10.3390/cancers14194870 · Cited by 43
Metadata
- Authors
- Vito, A., El-Sayes, N., & Mossman, K.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-04-16
- Volume
- 9
- Issue
- 4
- Pages
- 992
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3016364844
- Cited by
- 270
- References
- 153
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.